• FirefoxInstall the new Firefox »
  •  Dow Up 0.21% Nasdaq Up 0.32%

    Progenics Pharmaceuticals, Inc. (PGNX)

    -NasdaqGS
    6.82 Mar 5, 4:00PM EST
    Add to Portfolio
    Prev Close:6.82
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:8.67
    Beta:2.63
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:N/A - N/A
    52wk Range:3.10 - 7.84
    Volume:0
    Avg Vol (3m):872,280
    Market Cap:474.37M
    P/E (ttm):56.83
    EPS (ttm):0.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PGNX

    Comparison

    Symbol% ChgMkt Cap
    PGNX 0.00%474.37M
    DNDNN/A
    NKTR1.75B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):9.90
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.13
    Quarterly EPS Est (Dec-14) :-0.13
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):2.16

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Progenics Pharmaceuticals, Inc. develops medicines for oncology. The company offers Relistor-subcutaneous injection for the treatment of opioid induced constipation (OIC) in advanced-illness patients receiving palliative care when laxative therapy... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback